Skip to main content

Table 3 Hormonal laboratory data

From: Isolated adrenocorticotropic hormone deficiency development during chemotherapy for gastric cancer: a case report

   

Reference range

   

Reference range

ACTH

<5.0

pg/mL

(7.4–55.7)

FT3

1.6

pg/mL

(2.4–4.3)

TSH

4.63

μU/mL

(0.24–3.70)

FT4

1.0

ng/dL

(0.9–1.8)

LH

23.2

mIU/mL

(1.22–7.05)

TPO ab

<10.0

IU/mL

(<28.0)

FSH

31.1

mIU/mL

(2.00–8.30)

Tg ab

5.1

IU/mL

(<16.0)

GH

3.23

ng/mL

(<0.42)

    

PRL

44.38

ng/mL

(3.58–12.78)

Urinary cortisol

Not detected

μg/day

(11–80)

Renin

2.1

pg/mL

(0.3–2.9)

Antipituitary antibody

 

(−)

(−)

Somatomedin C

68

ng/mL

(42–250)

    

Cortisol

0.4

μg/dL

(4.0–18.3)

    

DHEA-S

10

ng/mL

(140–2240)

    

Aldosterone

59.0

pg/mL

(29.9–159)

    

CRH* test (human corticorelin 100μg i.v.)

 

Minutes

0

15

30

60

90

120

 

ACTH (pg/mL)

5.3

5.8

5.6

6.0

5.1

5.4

 

Cortisol (μg/dL)

<1.0

<1.0

<1.0

<1.0

<1.0

<1.0

  1. Abbreviations: ACTH adrenocorticotropic hormone, CRH corticotropin-releasing hormone, DHEA-S dehydroepiandrosterone sulfate, FSH follicle-stimulating hormone, FT3 free triiodothyronine, FT4 free thyroxine, GH growth hormone, i.v. intravenous, LH luteinizing hormone, PRL prolactin, Tg ab thyroglobulin antibody, TPO ab thyroid peroxidase antibody, TSH thyroid-stimulating hormone.